US Patent 7087645 Compounds and methods for treating transplant rejection
Patent 7087645 was granted and assigned to Atherogenics on August, 2006 by the United States Patent and Trademark Office.
All edits
Edits on 6 Sep, 2023
Golden AI
Edits made to:
Infobox (+3 properties)
Infobox
Patent Inventor Names
David B. Edwards0
Mitchell Glass0
Patricia K. Somers0
Edits on 29 Aug, 2023
Golden AI
Edits made to:
Article (+50 characters)
Article
Patent abstract
The use of compounds of the formula
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07087645 Compounds and methods for treating transplant rejection US Patent 7087645 Compounds and methods for treating transplant rejection
Infobox
Patent Number
070876450
Patent Number
70876450
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
070876450
Date of Patent
August 8, 2006
0Patent Application Number
107447630
Date Filed
December 23, 2003
0Official Website
Patent Primary Examiner
Edits on 7 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 16 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07087645 Compounds and methods for treating transplant rejection
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07087645
Date of patent
August 8, 2006
Patent application number
10744763
Date Filed
December 23, 2003
Patent primary examiner
Find more entities like US Patent 7087645 Compounds and methods for treating transplant rejection
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
